Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Proceedings of the National Academy of Sciences of the United States of America Année : 2006

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.

Résumé

We describe that galectin-1 (gal-1) is a receptor for the angiogenesis inhibitor anginex, and that the protein is crucial for tumor angiogenesis. gal-1 is overexpressed in endothelial cells of different human tumors. Expression knockdown in cultured endothelial cells inhibits cell proliferation and migration. The importance of gal-1 in angiogenesis is illustrated in the zebrafish model, where expression knockdown results in impaired vascular guidance and growth of dysfunctional vessels. The role of gal-1 in tumor angiogenesis is demonstrated in gal-1-null mice, in which tumor growth is markedly impaired because of insufficient tumor angiogenesis. Furthermore, tumor growth in gal-1-null mice no longer responds to antiangiogenesis treatment by anginex. Thus, gal-1 regulates tumor angiogenesis and is a target for angiostatic cancer therapy.

Domaines

Cancer
Fichier principal
Vignette du fichier
Thijssen_PNAS_2006.pdf (2.46 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-00109326 , version 1 (07-12-2006)

Identifiants

Citer

Victor L. J. L. Thijssen, Ruben Postel, Ricardo J. M. G. E. Brandwijk, Ruud P. M. Dings, Irina Nesmelova, et al.. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.. Proceedings of the National Academy of Sciences of the United States of America, 2006, 103 (43), pp.15975-80. ⟨10.1073/pnas.0603883103⟩. ⟨hal-00109326⟩
205 Consultations
397 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More